Male Infertility Market is anticipated to reach US$ 4.85 Bn by 2029 from US$ 3.44 Bn. in 2022 at a CAGR of 4.8% during a forecast period.Male Infertility Market Overview
Male infertility is described as a male counterpart's inability to induce conception in a fertile female. Male infertility is typically caused by a low sperm count, hormonal issues, or a lack of motile sperm. The brain, pituitary gland, and testes must all operate normally for a male to be fertile. Consumption of alcohol and drugs, growing stress levels, obesity, smoking, and environmental pollutants are some of the other major reasons for male infertility. According to WHO estimates, infertility affects 48 million couples and 186 million people globally.To know about the Research Methodology :- Request Free Sample Report The report has covered the market trends from 2015 to forecast the market through 2029. 2022 is considered a base year however 2020’s numbers are on the real output of the companies in the market. Special attention is given to 2020 and the effect of lockdown on the demand and supply, and also the impact of lockdown for the next two years on the market. Some companies have done well in lockdown also and specific strategic analysis of those companies is done in the report.
Male Infertility Market Dynamics
Advances in medical diagnostics, as well as rising male infertility, are driving the demand for male infertility. Infertility due to lifestyle-related disorders, rising obesity and an aging population are also expected to fuel market growth throughout the forecast period. However, as people become more conscious of their health problems and are willing to break through cultural barriers by admitting the reality of male infertility and pursuing treatment options, the market for male infertility treatments is growing.Continuous research and development efforts are being done to evaluate the condition of idiopathic infertility. As a result, companies are investing in the development of root-cause detection and targeted-treatment technologies. Additionally, the manufacturing and commercialization of hormone treatment are likely to boost demand for male infertility throughout the forecast period. Governments throughout the world have taken measures to improve the outlook for infertility-related therapy. Also, better patient data security as a result of law uniformity is likely to boost consumer demand for infertility therapy. The high cost of therapy is a significant barrier for most who need it. Another limiting element of male infertility treatment is the frequency of recurrent treatment failures, which is leading to the patient opting out of the treatment.
Male Infertility Market Segmentation Analysis
By Test Type, The DNA Fragmentation technique is expected to grow steadily in the future, owing to widespread use and the capacity of the diagnostic technique to provide an accurate examination of sperm DNA integrity. One of the primary reasons affecting male infertility is DNA fragmentation in sperm. This method is used to determine male infertility for diagnostic purposes. DNA fragmentation accounted for the biggest market share in 2022, since diagnostic procedures may give a reliable evaluation of sperm DNA integrity. DNA fragmentation is a relatively recent technology that has quickly acquired popularity in developing countries and is now extensively utilized.Male Infertility Market Regional Insights
Europe dominated the market in 2022, with a market share of 31.2 percent, and this dominance is expected to continue during the forecast period. The region's growth is being fueled by an aging population, diseases, and a rising acceptance of less invasive procedures. Furthermore, the existence of a significant number of modern and well-equipped specialist reproductive clinics, as well as manufacturing firms, is expected to fuel market growth in this region. North America is the second-largest male infertility market because of reasons such as growing occurrences of male infertility due to lifestyle variables such as obesity and diet, and technical developments that are meeting necessity treatment. The male infertility market is also benefiting from an increase in medical tourism and homosexuality in the United States. Due to the growing population, increased awareness of male infertility conditions, and readily available treatment options, the Male Infertility Market in the Asia Pacific is expected to grow during the forecast period. Although the government supports the adoption of technological advancements, infertility treatments are rarely covered by private or public insurance policies, restricting access to treatment for low-income people in this region.Competitive Landscape
Major players are adopting long-term strategies to acquire competitive advantages, such as new product launches, product upgrades, mergers and acquisitions, and collaboration partnerships. as an example, in June 2020, Inspiration Healthcare agreed to buy S.L.E., a business that designs and manufactures ventilators for neonatal critical care. The purchase might help the firm become a market leader in neonatal critical care. The purchase would also extend the company's product line and global distribution network. Inspiration Healthcare acquired Viomedex, a medical device maker, in December 2019. The purchase extended the company's product line and created prospects for expansion into the neonatal critical care market. Drager cooperated with Florida Hospital in May 2020, after which the latter business deployed Drager's Babyleo TN500 IncuWarmer beds. The beds are in use in three hospitals in Central Florida's health system's Neonatal Intensive Care Units (NICU).Male Infertility Market Scope: Inquire before buying
Male Infertility Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2017 to 2022 Market Size in 2022: US $ 3.44 Bn. Forecast Period 2023 to 2029 CAGR: 4.8% Market Size in 2029: US $ 4.85 Bn. Segments Covered: by Test Type • DNA Fragmentation Technique • Oxidative Stress Analysis • Sperm Agglutination • Computer Assisted Semen Analysis • Sperm Penetration Assay • others by Treatment • Assisted Reproductive Technology & Surgery • Hormone Treatment & Medications Male Infertility Market, by Region
• North America (United States, Canada and Mexico) • Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) • Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) • Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) • South America (Brazil, Argentina Rest of South America)Male Infertility Market: Key Players
• Bayer Healthcare, Inc • EMD Sereno • Aytu BioScience, Inc • Halotech DNA SL • Intas Pharmaceuticals Ltd • Cadila Healthcare Ltd • Andrology Solutions • SCSA diagnostics, Inc • Endo International plc • Vitrolife • Merck KGaA • Access Pharmaceuticals, Inc • Andrology Solutions • ASKA Pharmaceutical Co. Ltd • Cordex Pharma, Inc Frequently Asked Questions: 1. Which region has the largest share in Global Male Infertility Market? Ans: Europe region held the highest share in 2022. 2. What is the growth rate of Global Male Infertility Market? Ans: The Global Male Infertility Market is growing at a CAGR of 4.8% during forecasting period 2023-2029. 3. What is scope of the Global Male Infertility Market report? Ans: Global Male Infertility Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Male Infertility Market? Ans: The important key players in the Global Male Infertility Market are –Bayer Healthcare, Inc, EMD Sereno, Aytu BioScience, Inc, Halotech DNA SL, Intas Pharmaceuticals Ltd, Cadila Healthcare Ltd, Andrology Solutions, SCSA diagnostics, Inc, Endo International plc, Vitrolife, Merck KGaA, Access Pharmaceuticals, Inc, Andrology Solutions, ASKA Pharmaceutical Co. Ltd, Cord 5. What is the study period of this Market? Ans:ex Pharma, and Inc The Global Male Infertility Market is studied from 2022 to 2029.
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Male Infertility Market Size, by Market Value (US$ Bn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2022 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Male Infertility Market 3.4. Geographical Snapshot of the Male Infertility Market, By Manufacturer share 4. Global Male Infertility Market Overview, 2022-2029 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Products 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Male Infertility Market 5. Supply Side and Demand Side Indicators 6. Global Male Infertility Market Analysis and Forecast, 2022-2029 6.1. Global Male Infertility Market Size & Y-o-Y Growth Analysis. 7. Global Male Infertility Market Analysis and Forecasts, 2022-2029 7.1. Market Size (Value) Estimates & Forecast By Test Type,2022-2029 7.1.1. DNA Fragmentation Technique 7.1.2. Oxidative Stress Analysis 7.1.3. Sperm Agglutination 7.1.4. Computer Assisted Semen Analysis 7.1.5. Sperm Penetration Assay 7.1.6. others 7.2. Market Size (Value) Estimates & Forecast By Treatment ,2022-2029 7.2.1. Assisted Reproductive Technology & Surgery 7.2.2. Hormone Treatment & Medications 8. Global Male Infertility Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2022-2029 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Male Infertility Market Analysis and Forecasts, 2022-2029 9.1. Market Size (Value) Estimates & Forecast By Test Type,2022-2029 9.1.1. DNA Fragmentation Technique 9.1.2. Oxidative Stress Analysis 9.1.3. Sperm Agglutination 9.1.4. Computer Assisted Semen Analysis 9.1.5. Sperm Penetration Assay 9.1.6. others 9.2. Market Size (Value) Estimates & Forecast By Treatment ,2022-2029 9.2.1. Assisted Reproductive Technology & Surgery 9.2.2. Hormone Treatment & Medications 10. North America Male Infertility Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Male Infertility Market Analysis and Forecasts, 2022-2029 11.1. Market Size (Value) Estimates & Forecast By Test Type,2022-2029 11.2. Market Size (Value) Estimates & Forecast By Treatment ,2022-2029 12. Canada Male Infertility Market Analysis and Forecasts, 2022-2029 12.1. Market Size (Value) Estimates & Forecast By Test Type,2022-2029 12.2. Market Size (Value) Estimates & Forecast By Treatment ,2022-2029 13. Mexico Male Infertility Market Analysis and Forecasts, 2022-2029 13.1. Market Size (Value) Estimates & Forecast By Test Type,2022-2029 13.2. Market Size (Value) Estimates & Forecast By Treatment ,2022-2029 14. Europe Male Infertility Market Analysis and Forecasts, 2022-2029 14.1. Market Size (Value) Estimates & Forecast By Test Type,2022-2029 14.2. Market Size (Value) Estimates & Forecast By Treatment ,2022-2029 15. Europe Male Infertility Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. Male Infertility Market Analysis and Forecasts, 2022-2029 16.1. Market Size (Value) Estimates & Forecast By Test Type,2022-2029 16.2. Market Size (Value) Estimates & Forecast By Treatment ,2022-2029 17. France Male Infertility Market Analysis and Forecasts, 2022-2029 17.1. Market Size (Value) Estimates & Forecast By Test Type,2022-2029 17.2. Market Size (Value) Estimates & Forecast By Treatment ,2022-2029 18. Germany Male Infertility Market Analysis and Forecasts, 2022-2029 18.1. Market Size (Value) Estimates & Forecast By Test Type,2022-2029 18.2. Market Size (Value) Estimates & Forecast By Treatment ,2022-2029 19. Italy Male Infertility Market Analysis and Forecasts, 2022-2029 19.1. Market Size (Value) Estimates & Forecast By Test Type,2022-2029 19.2. Market Size (Value) Estimates & Forecast By Treatment ,2022-2029 20. Spain Male Infertility Market Analysis and Forecasts, 2022-2029 20.1. Market Size (Value) Estimates & Forecast By Test Type,2022-2029 20.2. Market Size (Value) Estimates & Forecast By Treatment ,2022-2029 21. Sweden Male Infertility Market Analysis and Forecasts, 2022-2029 21.1. Market Size (Value) Estimates & Forecast By Test Type,2022-2029 21.2. Market Size (Value) Estimates & Forecast By Treatment ,2022-2029 22. CIS Countries Male Infertility Market Analysis and Forecasts, 2022-2029 22.1. Market Size (Value) Estimates & Forecast By Test Type,2022-2029 22.2. Market Size (Value) Estimates & Forecast By Treatment ,2022-2029 23. Rest of Europe Male Infertility Market Analysis and Forecasts, 2022-2029 23.1. Market Size (Value) Estimates & Forecast By Test Type,2022-2029 23.2. Market Size (Value) Estimates & Forecast By Treatment ,2022-2029 24. Asia Pacific Male Infertility Market Analysis and Forecasts, 2022-2029 24.1. Market Size (Value) Estimates & Forecast By Test Type,2022-2029 24.2. Market Size (Value) Estimates & Forecast By Treatment ,2022-2029 25. Asia Pacific Male Infertility Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Male Infertility Market Analysis and Forecasts, 2022-2029 26.1. Market Size (Value) Estimates & Forecast By Test Type,2022-2029 26.2. Market Size (Value) Estimates & Forecast By Treatment ,2022-2029 27. India Male Infertility Market Analysis and Forecasts, 2022-2029 27.1. Market Size (Value) Estimates & Forecast By Test Type,2022-2029 27.2. Market Size (Value) Estimates & Forecast By Treatment ,2022-2029 28. Japan Male Infertility Market Analysis and Forecasts, 2022-2029 28.1. Market Size (Value) Estimates & Forecast By Test Type,2022-2029 28.2. Market Size (Value) Estimates & Forecast By Treatment ,2022-2029 29. South Korea Male Infertility Market Analysis and Forecasts, 2022-2029 29.1. Market Size (Value) Estimates & Forecast By Test Type,2022-2029 29.2. Market Size (Value) Estimates & Forecast By Treatment ,2022-2029 30. Australia Male Infertility Market Analysis and Forecasts, 2022-2029 30.1. Market Size (Value) Estimates & Forecast By Test Type,2022-2029 30.2. Market Size (Value) Estimates & Forecast By Treatment ,2022-2029 31. ASEAN Male Infertility Market Analysis and Forecasts, 2022-2029 31.1. Market Size (Value) Estimates & Forecast By Test Type,2022-2029 31.2. Market Size (Value) Estimates & Forecast By Treatment ,2022-2029 32. Rest of Asia Pacific Male Infertility Market Analysis and Forecasts, 2022-2029 32.1. Market Size (Value) Estimates & Forecast By Test Type,2022-2029 32.2. Market Size (Value) Estimates & Forecast By Treatment ,2022-2029 33. Middle East Africa Male Infertility Market Analysis and Forecasts, 2022-2029 33.1. Market Size (Value) Estimates & Forecast By Test Type,2022-2029 33.2. Market Size (Value) Estimates & Forecast By Treatment ,2022-2029 34. Middle East Africa Male Infertility Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Male Infertility Market Analysis and Forecasts, 2022-2029 35.1. Market Size (Value) Estimates & Forecast By Test Type,2022-2029 35.2. Market Size (Value) Estimates & Forecast By Treatment ,2022-2029 36. GCC Countries Male Infertility Market Analysis and Forecasts, 2022-2029 36.1. Market Size (Value) Estimates & Forecast By Test Type,2022-2029 36.2. Market Size (Value) Estimates & Forecast By Treatment ,2022-2029 37. Egypt Male Infertility Market Analysis and Forecasts, 2022-2029 37.1. Market Size (Value) Estimates & Forecast By Test Type,2022-2029 37.2. Market Size (Value) Estimates & Forecast By Treatment ,2022-2029 38. Nigeria Male Infertility Market Analysis and Forecasts, 2022-2029 38.1. Market Size (Value) Estimates & Forecast By Test Type,2022-2029 38.2. Market Size (Value) Estimates & Forecast By Treatment ,2022-2029 39. Rest of ME&A Male Infertility Market Analysis and Forecasts, 2022-2029 39.1. Market Size (Value) Estimates & Forecast By Test Type,2022-2029 39.2. Market Size (Value) Estimates & Forecast By Treatment ,2022-2029 40. South America Male Infertility Market Analysis and Forecasts, 2022-2029 40.1. Market Size (Value) Estimates & Forecast By Test Type,2022-2029 40.2. Market Size (Value) Estimates & Forecast By Treatment ,2022-2029 41. South America Male Infertility Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Male Infertility Market Analysis and Forecasts, 2022-2029 42.1. Market Size (Value) Estimates & Forecast By Test Type,2022-2029 42.2. Market Size (Value) Estimates & Forecast By Treatment ,2022-2029 43. Argentina Male Infertility Market Analysis and Forecasts, 2022-2029 43.1. Market Size (Value) Estimates & Forecast By Test Type,2022-2029 43.2. Market Size (Value) Estimates & Forecast By Treatment ,2022-2029 44. Rest of South America Male Infertility Market Analysis and Forecasts, 2022-2029 44.1. Market Size (Value) Estimates & Forecast By Test Type,2022-2029 44.2. Market Size (Value) Estimates & Forecast By Treatment ,2022-2029 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Male Infertility Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 45.2.2. New Product Launches and Product Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Applications 45.2.3.2. M&A Key Players, Forward Integration and Backward Integration 45.3. Company Profile: Key Players 45.3.1. EMD Sereno 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Product Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.4. Bayer Healthcare, Inc 45.5. EMD Sereno 45.6. Aytu BioScience, Inc 45.7. Halotech DNA SL 45.8. Intas Pharmaceuticals Ltd 45.9. Cadila Healthcare Ltd 45.10. Andrology Solutions 45.11. SCSA diagnostics, Inc 45.12. Endo International plc 45.13. Vitrolife 45.14. Merck KGaA 45.15. Access Pharmaceuticals, Inc 45.16. Andrology Solutions 45.17. ASKA Pharmaceutical Co. Ltd 45.18. Cordex Pharma, Inc 46. Primary Key Insights